Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Parkinson's patients under risk of developing dementia can be identified quickly, say researchers

It may now be possible to identify the first-stage Parkinson's patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Université de Montréal.

11 Mar 2014

Singapore's largest institute launched to improve treatment for stroke, Parkinson disease

The National Neuroscience Research Institute Singapore - a joint venture by the National Neuroscience Institute and Duke-NUS Graduate Medical School - has been launched to improve treatment and seek cures through research for brain and nervous system disorders such as stroke, Parkinson disease and dementia.

11 Mar 2014

FDA accepts Lundbeck's carbamazepine NDA for review

Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.

10 Mar 2014

Men who have poorer cardiovascular fitness at 18 years more often suffer from dementia before 60

Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.

10 Mar 2014

Healthy dietary choices in midlife may prevent dementia in later years

Healthy dietary choices in midlife may prevent dementia in later years, according a doctoral thesis published at the University of Eastern Finland. The results showed that those who ate the healthiest diet at the average age of 50 had an almost 90 per cent lower risk of dementia in a 14-year follow-up study than those whose diet was the least healthy.

10 Mar 2014

Decision-making accuracy can be improved by postponing onset of decision

Columbia University Medical Center (CUMC) researchers have found that decision-making accuracy can be improved by postponing the onset of a decision by a mere fraction of a second.

10 Mar 2014

Inherited Alzheimer's neuronal damage begins 10 to 20 years before symptoms appear

In a paper published in the prestigious journal Science Translational Medicine, Professor Colin Masters from the Florey Institute of Neuroscience and Mental Health and University of Melbourne - and colleagues in the UK and US - have found rapid neuronal damage begins 10 to 20 years before symptoms appear.

10 Mar 2014

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).

7 Mar 2014

BWH researchers explore newer approaches to treat Alzheimer's disease

A team of Alzheimer's disease (AD) researchers at Brigham and Women's Hospital (BWH) has been able to study the underlying causes of AD and develop assays to test newer approaches to treatment by using stem cells derived from related family members with a genetic predisposition to (AD).

7 Mar 2014

UH physicist to develop new therapies targeting cancer and Alzheimer's

Working toward new therapies to target cancer and Alzheimer's, University of Houston (UH) physicist Margaret Cheung strives to understand the physics that govern how ordinary matter becomes life-like.

7 Mar 2014

New findings shed light on how gene mutation causes motor neurone disease

Researchers have discovered a mechanism that may explain how a recently discovered mutation causes two devastating neurological diseases.

6 Mar 2014

New findings shed light on how gene mutation causes motor neurone disease

Researchers have discovered a mechanism that may explain how a recently discovered mutation causes two devastating neurological diseases.

6 Mar 2014

Alzheimer's disease may contribute to close to as many deaths as heart disease

A new study suggests that Alzheimer's disease may contribute to close to as many deaths in the United States as heart disease or cancer. The research is published in the March 5, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Mar 2014

Scientists reveal how a genetic code variation results in devastating brain diseases

New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.

6 Mar 2014

Minimally invasive surgery outcomes show favorable results in low back pain patients

Beaumont research findings published in the February online issue of Spine shows that patients who have a low back surgery called minimally invasive transforaminal lumbar interbody fusion, end up better off in many ways than patients who have more invasive surgery to alleviate debilitating pain.

5 Mar 2014

Ultra-high-field MRI provides detailed views of brain area implicated in Parkinson's disease

New research shows that ultra-high-field magnetic resonance imaging (MRI) provides detailed views of a brain area implicated in Parkinson's disease, possibly leading to earlier detection of a condition that affects millions worldwide. The results of this research are published online in the journal Radiology.

5 Mar 2014

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.

5 Mar 2014

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

5 Mar 2014

Stem cells from patients offer model, drug-discovery platform for early-onset form of Alzheimer's

Harvard stem cell scientists have successfully converted skins cells from patients with early-onset Alzheimer's into the types of neurons that are affected by the disease, making it possible for the first time to study this leading form of dementia in living human cells. This may also make it possible to develop therapies far more quickly and accurately than before.

5 Mar 2014

Researchers identify eight neural subnetworks in mammalian cerebral cortex

The mammalian cerebral cortex, long thought to be a dense single interrelated tangle of neural networks, actually has a "logical" underlying organizational principle, reveals a study appearing Feb. 27 in the journal Cell.

4 Mar 2014

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Parkinson's patients under risk of developing dementia can be identified quickly, say researchers

Singapore's largest institute launched to improve treatment for stroke, Parkinson disease

FDA accepts Lundbeck's carbamazepine NDA for review

Men who have poorer cardiovascular fitness at 18 years more often suffer from dementia before 60

Healthy dietary choices in midlife may prevent dementia in later years

Decision-making accuracy can be improved by postponing onset of decision

Inherited Alzheimer's neuronal damage begins 10 to 20 years before symptoms appear

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

BWH researchers explore newer approaches to treat Alzheimer's disease

UH physicist to develop new therapies targeting cancer and Alzheimer's

New findings shed light on how gene mutation causes motor neurone disease

New findings shed light on how gene mutation causes motor neurone disease

Alzheimer's disease may contribute to close to as many deaths as heart disease

Scientists reveal how a genetic code variation results in devastating brain diseases

Minimally invasive surgery outcomes show favorable results in low back pain patients

Ultra-high-field MRI provides detailed views of brain area implicated in Parkinson's disease

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Stem cells from patients offer model, drug-discovery platform for early-onset form of Alzheimer's

Researchers identify eight neural subnetworks in mammalian cerebral cortex

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in